Overall, these data suggest that autophagy could be induced during chemotherapy, and suppression of autophagic pathways using autophagy inhibitor have potential to improve the chemotherapeutic effectiveness in GC patients with ATG-5 high expression. The gene discussed is ATG5; the disease is gastric cancer.